Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant point » significant amount (Expand Search), significant part (Expand Search), significant event (Expand Search)
decrease based » disease based (Expand Search)
point decrease » point increase (Expand Search)
Showing 21 - 40 results of 23,737 for search '(( significant decrease based ) OR ( significant point decrease ))', query time: 1.63s Refine Results
  1. 21
    Summary of the earliest time point for significant WD-induced changes in NASH-associated markers.

    Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

    Published 2023
    “…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”
    Save to List
    Saved in:
  2. 22
    Change in the levels of parental stressors or rewards between time point 1 and time point 2.

    Change in the levels of parental stressors or rewards between time point 1 and time point 2. by Ragnhild Bjørknes (4908577)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 23
    Point cell model behavior.

    Point cell model behavior. by Evan Cudone (5768813)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 24
    Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and the neck-specific exercise at a physiotherapy clinic (NSE) group.

    Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 25
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 35
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 36
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 37
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 38
    Effect of mHealth application on FOC score in intervention group compared to control group at different time points (n = 70).

    Effect of mHealth application on FOC score in intervention group compared to control group at different time points (n = 70). by Sahar Khademioore (17319385)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 39
    PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice.

    PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)

    Published 2022
    Save to List
    Saved in:
  20. 40
    PointSite: A Point Cloud Segmentation Tool for Identification of Protein Ligand Binding Atoms

    PointSite: A Point Cloud Segmentation Tool for Identification of Protein Ligand Binding Atoms by Xu Yan (110026)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: